Endoscopic Prediction of Crohn's Disease Postoperative Recurrence

被引:26
作者
De Cruz, Peter [1 ,2 ,3 ]
Hamilton, Amy L. [1 ,2 ]
Burrell, Kathryn J. [1 ,2 ,3 ]
Gorelik, Alexandra [4 ]
Liew, Danny [5 ]
Kamm, Michael A. [1 ,2 ]
机构
[1] Univ Melbourne, Dept Gastroenterol, St Vincents Hosp, Melbourne, Vic, Australia
[2] Univ Melbourne, Dept Med, Melbourne, Vic, Australia
[3] Austin Hlth, Dept Gastroenterol, Melbourne, Vic, Australia
[4] Australian Catholic Univ, Dept Psychol, Melbourne, Vic, Australia
[5] Monash Univ, Dept Epidemiol & Preventat Med, Melbourne, Vic, Australia
关键词
IBD; Crohn's disease; postoperative recurrence; endoscopic scoring; mucosal healing; prognosis; response to therapy; PROSPECTIVE MULTICENTER; ILEOCOLIC RESECTION; ILEAL; AZATHIOPRINE; VALIDATION; MANAGEMENT; SEVERITY; EFFICACY; SURGERY; THERAPY;
D O I
10.1093/ibd/izab134
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background The presence and severity of endoscopic recurrence after Crohn's disease intestinal resection predicts subsequent disease course. The Rutgeerts postoperative endoscopic recurrence score is unvalidated but has proven prognostically useful in many clinical studies. This study aimed to investigate the association between specific early endoscopic findings and subsequent disease course. Methods In the setting of a randomized controlled trial (the POCER study), 85 patients underwent colonoscopy at 6 and 18 months after intestinal resection. Patients received 3 months of metronidazole, and high-risk patients received a thiopurine (or adalimumab if they were thiopurine intolerant). For endoscopic recurrence (Rutgeerts score >= i2) at 6 months, patients stepped up to a thiopurine, fortnightly adalimumab with thiopurine, or weekly adalimumab. Central readers confirmed Rutgeerts, Simple Endoscopic Score for Crohn's Disease, Crohn's Disease Endoscopic Index of Severity scores, and 5 newly tested endoscopic parameters: anastomotic ulcer depth (superficial vs deep), number of ulcers (0, <= 2, >2), ulcer size (1-5 mm, >= 6 mm), circumferential extent of ulceration (<25%, >= 25%), and the presence or absence of stenosis. The POCER index, based on the 6-month postoperative findings, was then developed in relation to predicting the endoscopic outcome at 18 months. Results Of the 5 parameters, the combination of ulcer depth and circumference at the anastomosis at 6 months was associated with endoscopic recurrence at 18 months (odds ratio [OR], 1.6; 95% confidence interval [CI], 1.03-2.50; P = 0.035) with an area under the receiver operating characteristic curve of 0.62 (95% CI, 0.5-0.75). The combination of these 2 parameters formed the basis of the POCER index (range, 0-4 with 0 denoting no ulcers and 4 denoting deep ulceration with >25% circumferential involvement). The new index had a strong correlation with the Rutgeerts score measured at the same time points: Spearmans' r = .80 at 6 months and r = .77 at 18 months (P < 0.001 at both time points). A POCER index of >= 2 and a Rutgeerts score of >= i2 both had a sensitivity of 0.41 for recurrence; however, the POCER index had a higher specificity (0.8 and 0.67, respectively). The POCER index at 6 months was associated with endoscopic recurrence at 18 months (OR, 1.5; 95% CI, 1.2-2.0; P = 0.002; area under the receiver operating characteristic curve of 0.70; 95% CI, 0.57-0.82), but the Rutgeerts score was not (OR, 1.2; 95% CI, 0.8-1.8; P = 0.402). Conclusions The POCER postoperative index comprises 2 key endoscopic factors related to the anastomosis that are associated with subsequent disease progression. A higher score, comprising the adverse prognostic factors of deep or circumferentially extensive anastomotic ulceration, may help identify patients who require more intensive therapy.
引用
收藏
页码:680 / 688
页数:9
相关论文
共 30 条
[1]   Ileal or Anastomotic Location of Lesions Does Not Impact Rate of Postoperative Recurrence in Crohn's Disease Patients Classified i2 on the Rutgeerts Score [J].
Bayart, P. ;
Duveau, N. ;
Nachury, M. ;
Zerbib, P. ;
Gerard, R. ;
Branche, J. ;
Maunoury, V. ;
Wils, Pauline ;
Boruchowicz, A. ;
Boualit, M. ;
Laberenne, J. -E. ;
Manolache, O. ;
Desreumaux, P. ;
de Chambrun, G. Pineton ;
Pariente, B. .
DIGESTIVE DISEASES AND SCIENCES, 2016, 61 (10) :2986-2992
[2]   CORRELATIONS BETWEEN CLINICAL ACTIVITY, ENDOSCOPIC SEVERITY, AND BIOLOGICAL PARAMETERS IN COLONIC OR ILEOCOLONIC CROHNS-DISEASE - A PROSPECTIVE MULTICENTER STUDY OF 121 CASES [J].
CELLIER, C ;
SAHMOUD, T ;
FROGUEL, E ;
ADENIS, A ;
BELAICHE, J ;
BRETAGNE, JF ;
FLORENT, C ;
BOUVRY, M ;
MARY, JY ;
MODIGLIANI, R ;
COLOMBEL, JF ;
CORTOT, A ;
LESCUT, D ;
BITOUN, A ;
LEMANN, M ;
SALMERON, M ;
THEROND, JP ;
VERNISSE, B ;
SEE, A ;
RAOUL, JL .
GUT, 1994, 35 (02) :231-235
[3]   Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial [J].
Colombel, Jean-Frederic ;
Panaccione, Remo ;
Bossuyt, Peter ;
Lukas, Milan ;
Baert, Filip ;
Vanasek, Tomas ;
Danalioglu, Ahmet ;
Novacek, Gottfried ;
Armuzzi, Alessandro ;
Hebuterne, Xavier ;
Travis, Simon ;
Danese, Silvio ;
Reinisch, Walter ;
Sandborn, William J. ;
Rutgeerts, Paul ;
Hommes, Daniel ;
Schreiber, Stefan ;
Neimark, Ezequiel ;
Huang, Bidan ;
Zhou, Qian ;
Mendez, Paloma ;
Petersson, Joel ;
Wallace, Kori ;
Robinson, Anne M. ;
Thakkar, Roopal B. ;
D'Haens, Geert .
LANCET, 2017, 390 (10114) :2779-2789
[4]   Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn's disease: A controlled randomized trial [J].
D'Haens, Geert R. ;
Vermeire, Severine ;
Van Assche, Gert ;
Noman, Maja ;
Aerden, Isolde ;
Van Olmew, Gust ;
Rutgeerts, Paul .
GASTROENTEROLOGY, 2008, 135 (04) :1123-1129
[5]   Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD [J].
Daperno, M ;
D'Haens, G ;
Van Assche, G ;
Baert, F ;
Bulois, P ;
Maunoury, V ;
Sostegni, R ;
Rocca, R ;
Pera, A ;
Gevers, A ;
Mary, JY ;
Colombel, JF ;
Rutgeerts, P .
GASTROINTESTINAL ENDOSCOPY, 2004, 60 (04) :505-512
[6]   Efficacy of thiopurines and adalimumab in preventing Crohn's disease recurrence in high-risk patients - a POCER study analysis [J].
De Cruz, P. ;
Kamm, M. A. ;
Hamilton, A. L. ;
Ritchie, K. J. ;
Krejany, E. O. ;
Gorelik, A. ;
Liew, D. ;
Prideaux, L. ;
Lawrance, I. C. ;
Andrews, J. M. ;
Bampton, P. A. ;
Jakobovits, S. ;
Florin, T. H. ;
Gibson, P. R. ;
Debinski, H. ;
Gearry, R. B. ;
Macrae, F. A. ;
Leong, R. W. ;
Kronborg, I. ;
Radford-Smith, G. ;
Selby, W. ;
Johnston, M. J. ;
Woods, R. ;
Elliott, P. R. ;
Bell, S. J. ;
Brown, S. J. ;
Connell, W. R. ;
Desmond, P. V. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 42 (07) :867-879
[7]   Crohn's disease management after intestinal resection: a randomised trial [J].
De Cruz, Peter ;
Kamm, Michael A. ;
Hamilton, Amy L. ;
Ritchie, Kathryn J. ;
Krejany, Efrosinia O. ;
Gorelik, Alexandra ;
Liew, Danny ;
Prideaux, Lani ;
Lawrance, Ian C. ;
Andrews, Jane M. ;
Bampton, Peter A. ;
Gibson, Peter R. ;
Sparrow, Miles ;
Leong, Rupert W. ;
Florin, Timothy H. ;
Gearry, Richard B. ;
Radford-Smith, Graham ;
Macrae, Finlay A. ;
Debinski, Henry ;
Selby, Warwick ;
Kronborg, Ian ;
Johnston, Michael J. ;
Woods, Rodney ;
Elliott, P. Ross ;
Bell, Sally J. ;
Brown, Steven J. ;
Connell, William R. ;
Desmond, Paul V. .
LANCET, 2015, 385 (9976) :1406-1417
[8]   Impact of azathioprine on the prevention of postoperative Crohn's disease recurrence:: Results of a prospective, observational, long-term follow-up study [J].
Domenech, Eugeni ;
Manosa, Miriam ;
Bernal, Isabel ;
Garcia-Planella, Esther ;
Cabre, Eduard ;
Pinol, Marta ;
Lorenzo-Zuniga, Vicente ;
Boix, Jaume ;
Gassull, Miguel A. .
INFLAMMATORY BOWEL DISEASES, 2008, 14 (04) :508-513
[9]  
Hammoudi N, 2020, J CROHNS COLITIS, V14, pS004
[10]   Anastomotic Ulcers After Ileocolic Resection for Crohn's Disease Are Common and Predict Recurrence [J].
Hirten, Robert P. ;
Ungaro, Ryan C. ;
Castaneda, Daniel ;
Lopatin, Sarah ;
Sands, Bruce E. ;
Colombel, Jean Frederic ;
Cohen, Benjamin L. .
INFLAMMATORY BOWEL DISEASES, 2020, 26 (07) :1050-1058